Anebulo Pharmaceuticals, Inc. (ANEB)

CIK 1815974 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Anebulo Pharmaceuticals, Inc..

Recent SEC filings

FiledFormAccession number
Mar 2, 202615-12G0001493152-26-008559
Feb 17, 2026250001493152-26-007168
Feb 13, 2026SCHEDULE 13G/A0001104659-26-015319
Feb 12, 20268-K0001493152-26-006428
Feb 12, 202610-Q0001493152-26-006446
Feb 6, 20268-K0001493152-26-005463
Jan 29, 20268-K0001493152-26-004154
Jan 29, 2026SC 13E3/A0001493152-26-004156
Jan 27, 2026SC 13E3/A0001493152-26-003720
Jan 27, 20268-K0001493152-26-003718
Jan 8, 2026SC 13E3/A0001493152-26-000914
Dec 22, 20258-K0001493152-25-028676
Dec 22, 2025SC TO-I0001493152-25-028680
Dec 22, 2025SC 13E30001493152-25-028828
Nov 13, 20258-K0001493152-25-022310
Nov 13, 202510-Q0001493152-25-022350
Oct 14, 2025SC 13E3/A0001493152-25-017826
Oct 10, 2025PRER14A0001493152-25-017820
Sep 29, 20258-K0001493152-25-016001
Sep 29, 202510-K0001493152-25-016015
Sep 26, 2025S-8 POS0001493152-25-015075
Sep 26, 2025S-8 POS0001493152-25-015078
Sep 23, 2025EFFECT9999999995-25-003060
Sep 23, 2025EFFECT9999999995-25-003064
Sep 19, 2025POS AM0001493152-25-014238